2001 Clinical Development Clinical Research Pharma Companies 
Drug Discovery World
OCTOBER 16, 2023
Despite the overall reduction in major pharma R&D centres in the UK, global pharma companies continue to engage with academic and biotech organisations here, particularly in hotspots such as the Golden Triangle, the Northwest, and Scotland, through the strong networks that have been developed between these organisations.
Drug Discovery World
OCTOBER 7, 2022
RA: How can the integration of industry and academia help streamline drug development? . TH : Increasingly, large pharma companies need scale, agility and access to academic partnerships to succeed. It is unsurprising that many pharma companies are increasingly keen to work with academia or academic spin-out.
Expert insights. Personalized for you.
189 
Let's personalize your content